Tania B. Kaprealian, MD, MBA

Tania Kaprealian, MD

Assistant Professor, Departments of Radiation Oncology and Neurosurgery


English, Armenian


Radiation Oncology

Institutional Affiliation

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica



Internal Medicine, VA Greater Los Angeles Healthcare System, 2005 - 2006


MD, UC San Francisco School of Medicine, 2004


Radiation Oncology, UCSF Department of Radiology, 2006 - 2010

Board Certification

Radiation Oncology, American Board of Radiology, 2014

Contact Information

Clinical Interests

Central Nervous System (CNS) Tumors

Scientific Interests

Dr. Tania Kaprealian's research interests are in the treatment of central nervous system (CNS) tumors both benign and malignant in both in adults and pediatrics. Her current projects are looking at innovative ways to use stereotactic radiosurgery in the treatment of these tumors. In addition, she has the first clinical protocol for the use of 4pi radiotherapy, a novel, high precision radiation therapy delivery technique devised at UCLA, for the treatment of recurrent glioblastomas.

Highlighted Publications

Nguyen D, Rwigema JC, Yu VY, Kaprealian T, Kupelian P, Selch M, Lee P, Low DA, Sheng K. Feasibility of extreme dose escalation for glioblastoma multiforme using 4pi radiotherapy. Radiat Oncol. 2014 Nov 7;9(1):239. [Epub ahead of print]

Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M 3rd, Shinohara K, Hsu IC. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):222-7. doi: 10.1016/j.ijrobp.2010.09.021. Epub 2010 Dec 14.

Ermoian RP, Kaprealian T, Lamborn KR, Yang X, Jelluma N, Arvold ND, Zeidman R, Berger MS, Stokoe D, Haas-Kogan DA. Signal transduction molecules in gliomas of all grades. J Neurooncol. 2009 Jan;91(1):19-26. doi: 10.1007/s11060-008-9683-5. Epub 2008 Sep 1.

Quinones-Hinojosa A, Kaprealian T, Chaichana KL, Sanai N, Parsa AT, Berger MS, McDermott MW. Pre-operative factors affecting resectability of giant intracranial meningiomas. Can J Neurol Sci. 2009 Sep;36(5):623-30.